Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagy
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Significance: In mitophagy, damaged mitochondria are targeted for disposal by the autophagy machinery. PARKIN promotes signaling of mitochondrial damage to the autophagy machinery for engagement, and PARKIN mutations cause Parkinson’s disease, possibly because damaged mitochondria accumulate in neurons. Because regulation of PARKIN abundance and the impact on signaling are poorly understood, we performed a genetic screen to identify PARKIN abundance regulators. Both positive and negative regulators were identified and will help us to further understand mitophagy and Parkinson’s disease. We show that some of the identified genes negatively regulate PARKIN gene expression, which impacts signaling of mitochondrial damage in mitophagy. This link between transcriptional repression and mitophagy is also apparent in neurons in culture, bearing implications for disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4. THAP11 is part of a functional gene network mediating transcriptional repression of endogenous PARKIN in JumpIN cells. (A) THAP11, HCFC1, and OGT negatively regulate PARK2 mRNA level. PARK2 mRNA level relative to HPRT1 was determined by qPCR on total RNA extracted from stable cell pools of parental JumpIN cells expressing nontargeting (SCR), THAP11- (second strongest sgRNA from screen), HCFC1-, or OGT-specific sgRNAs (strongest sgRNA in screen); n = 3; error bars indicate SDs. **P < 0.01, ***P < 0.001. Average CRISPR/Cas9 editing efficiencies were assessed by TIDE. (B) Targeting of either OGT (Left) or THAP11 (Right) negatively affects endogenous PARKIN protein level. Stable pools of parental cells as in A were analyzed by WB using antibodies indicated. *Nonspecific cross-reaction. CRISPR/Cas9 editing efficiencies were assessed by TIDE. (C and D) Parental cells were infected with THAP11-specific (second strongest sgRNA in screen) or SCR sgRNAs in triplicates for 15 d. Cell extracts were subjected to RNAseq (C), qPCR (D), or WB to assess THAP11 depletion and PARKIN protein elevation (Fig. S4B). In C, transcript fold-changes of THAP11-targeted vs. SCR samples (x-axis, log2) were plotted against P values (y axis, −log10). For hit calling, thresholds were set to <−1 and >1 log2 fold-changes and P < 0.01. The 10 genes most strongly repressed are labeled in blue. PACRG is also repressed by THAP11 (green). (D) qPCR using Taqman probes indicated, scored relative to GAPDH or HPRT1 (PACRG) mRNA, normalized to SCR control. n = 3; error bars indicate SDs. **P < 0.01, ***P < 0.001. (E) Gene-set enrichment analysis suggests modulation of diverse biological processes upon THAP11 depletion. Enrichment analysis for RNAseq using a weighted one-sided Kolmogorov-Smirnov test; test statistic D and negative logarithm (base 10) of adjusted P values are reported. The 10 most enriched sets among up-regulated (Upper) or down-regulated (Lower) transcripts are shown. (F) Comparison of the RNAseq dataset from THAP11-depleted JumpIN cells with data from Poché et al. (29), showing numbers of transcripts regulated by THAP11 in either one or both experiments [cutoff <−1 and >1 fold-changes (log2); P < 0.01]; genes commonly regulated by THAP11 are listed. eff., efficiency; fc, fold-change; ref., reference transcript; rel., relative; WB, Western blot.](https://figures.cochat.ai/paper-figures/ae61383deef5445eae5b9c3c20d12b6d/genome-wide-crispr-screen-for-parkin-regulators-reveals-transcriptional-figure-4.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Recently, we implemented large-scale CRISPR-based genetic screens for the first time in a human iPSC-derived differentiated cell type, namely neurons76.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [76]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Third, an arrayed longitudinal imaging screens uncovered consequences of gene knockdown for neuron-specific morphological features, such as neurite length and branching patterns76, which could not have been evaluated in other cell types.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [76]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Second, housekeeping genes that were essential for survival of both iPSCs and neurons may play different roles in the two cell types, based on vastly different transcriptomic consequences of their knockdown76.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [76]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“CRISPR screening recovered a previously known key regulator of neuronal cell death, MAP3K12/DLK76.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [76]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“First, the set of genes controlling survival of neurons were distinct from those controlling cancer cell or iPSC survival.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [76]
Experimental — accuracy not yet measured
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
MEME SUITE: tools for motif discovery and searching
Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., Li, W. W., & Noble, W. S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp335 · Cited by 10,648
STRING v10: protein–protein interaction networks, integrated over the tree of life
Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1003 · Cited by 10,436
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 2×
“Mutations in both PINK1 and PARKIN are a cause of familial Parkinson’s disease, suggesting that compromised mitophagy is an underlying feature (10, 11).”
BackgroundPruitt, K. D., Tatusova, T., & Maglott, D. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl842 · Cited by 4,481
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
Lazarou, M., Sliter, D. A., Kane, L. A., Sarraf, S. A., Wang, C., Burman, J. L., Sideris, D. P., Fogel, A. I., & Youle, R. J. (2015) · Nature · doi:10.1038/nature14893 · Cited by 2,774
Easy quantitative assessment of genome editing by sequence trace decomposition
Brinkman, E. K., Chen, T., Amendola, M., & van Steensel, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku936 · Cited by 2,390 · cited 1×
“In some cases, the effects were mild, which can be partially explained by inefficient editing as assessed by the TIDE (Tracking of Indels by Decomposition) sequence trace composition assay (27) (Fig.”
MethodThe Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
Matsuda, N., Sato, S., Shiba, K., Okatsu, K., Saisho, K., Gautier, C. A., Sou, Y.-S., Saiki, S., Kawajiri, S., Sato, F., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910140 · Cited by 1,969 · cited 1×
“1E), reflecting PARKIN activation, where the GFP-tag serves as a pseudo-substrate (21).”
BackgroundGenome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Rapid single-step induction of functional neurons from human pluripotent stem cells
Zhang, Y., Pak, C., Han, Y., Ahlenius, H., Zhang, Z., Chanda, S., Marro, S., Patzke, C., Acuna, C., Covy, J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.029 · Cited by 1,644 · cited 1×
“THAP11 was targeted in human iPSCs carrying iNGN2 for rapid single-step induction of functional neurons (33) (iPSC iNGN2 cells) (Fig.”
BackgroundIdentification and characterization of essential genes in the human genome
Wang, T., Birsoy, K., Hughes, N. W., Krupczak, K. M., Post, Y., Wei, J. J., Lander, E. S., & Sabatini, D. M. (2015) · Science · doi:10.1126/science.aac7041 · Cited by 1,617 · cited 1×
“Comparing fold-changes in the “unsorted” population, we observed that the essential gene set from KBM7 cells (24) was enriched among genes with strong negative fold-changes, suggesting that these genes are also essential in endoGFP-PARKIN cells and demonstrating efficient genome-wide editing in the pooled screening mo…”
Ubiquitin is phosphorylated by PINK1 to activate parkin
Koyano, F., Okatsu, K., Kosako, H., Tamura, Y., Go, E., Kimura, M., Kimura, Y., Tsuchiya, H., Yoshihara, H., Hirokawa, T., et al. (2014) · Nature · doi:10.1038/nature13392 · Cited by 1,477
Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin
Tanaka, A., Cleland, M. M., Xu, S., Narendra, D. P., Suen, D.-F., Karbowski, M., & Youle, R. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201007013 · Cited by 1,369 · cited 5×
“F - α-PARKIN (endogenous) A / O (10 / 5 μM) sgRNA (stable pools) - 30’ 120’60’- 30’60’ 120’ parental SCR PARK2 #i - α-MFN2 - α-Actin endoGFP-PARKIN sgRNA (stable pools)SCR PARK2 #i - α-PARKIN (GFP-PARKIN) - α-Actin Ub-MFN2MFN2- A / O (10 / 5 μM)- 30’ 120’60’- 30’60’ 120’ - α-MFN2Ub-MFN2MFN2- 52 kDa - 76 kDa - 102 kDa…”
BackgroundResultInfluentialPINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity
Kane, L. A., Lazarou, M., Fogel, A. I., Li, Y., Yamano, K., Sarraf, S. A., Banerjee, S., & Youle, R. J. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201402104 · Cited by 1,298
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Cirulli, E. T., Lasseigne, B. N., Petrovski, S., Sapp, P. C., Dion, P. A., Leblond, C. S., Couthouis, J., Lu, Y.-F., Wang, Q., Krueger, B. J., et al. (2015) · Science · doi:10.1126/science.aaa3650 · Cited by 966
Heo, J.-M., Ordureau, A., Paulo, J. A., Rinehart, J., & Harper, J. W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.08.016 · Cited by 906
Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65
Kazlauskaite, A., Kondapalli, C., Gourlay, R., Campbell, D. G., Ritorto, M. S., Hofmann, K., Alessi, D. R., Knebel, A., Trost, M., & Muqit, M. M. K. (2014) · Biochemical Journal · doi:10.1042/bj20140334 · Cited by 806
Narendra, D., Kane, L. A., Hauser, D. N., Fearnley, I. M., & Youle, R. J. (2010) · Autophagy · doi:10.4161/auto.6.8.13426 · Cited by 790
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Freischmidt, A., Wieland, T., Richter, B., Ruf, W., Schaeffer, V., Müller, K., Marroquin, N., Nordin, F., Hübers, A., Weydt, P., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4000 · Cited by 786 · cited 1×
“Pathogenic mutations in TBK1 as well as PARK2 have been identified in amyotrophic lateral sclerosis-frontotemporal dementia and Parkinson’s disease, respectively, thereby encouraging speculation that low signal amplification upon mitochondrial damage is of pathophysiological importance (10, 36, 37).”
BackgroundRichter, B., Sliter, D. A., Herhaus, L., Stolz, A., Wang, C., Beli, P., Zaffagnini, G., Wild, P., Martens, S., Wagner, S. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523926113 · Cited by 755 · cited 2×
“Concomitant with receptor recruitment, the TBK1 kinase is activated and TBK1-mediated receptor phosphorylation promotes receptor ubiquitin chain binding and further TBK1 activation, thereby revealing another feed-forward mechanism (8, 34, 35).”
BackgroundOrdureau, A., Sarraf, S. A., Duda, D. M., Heo, J.-M., Jedrychowski, M. P., Sviderskiy, V. O., Olszewski, J. L., Koerber, J. T., Xie, T., Beausoleil, S. A., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.007 · Cited by 697
Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation
Matheoud, D., Sugiura, A., Bellemare-Pelletier, A., Laplante, A., Rondeau, C., Chemali, M., Fazel, A., Bergeron, J. J., Trudeau, L.-E., Burelle, Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.039 · Cited by 582 · cited 1×
“The E3 ligase PARKIN (encoded by the PARK2 gene) takes on the role of a major sentinel that integrates multiple quality-control mechanisms ranging from facilitating proteasomal degradation of mitochondrial proteins to suppressing mitochondrial antigen presentation (2, 3).”
BackgroundValente, E. M., Bentivoglio, A. R., Dixon, P. H., Ferraris, A., Ialongo, T., Frontali, M., Albanese, A., & Wood, N. W. (2001) · The American Journal of Human Genetics · doi:10.1086/319522 · Cited by 493
Inferring direct DNA binding from ChIP-seq
Bailey, T. L., & Machanick, P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks433 · Cited by 462
Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice
Gong, G., Song, M., Csordas, G., Kelly, D. P., Matkovich, S. J., & Dorn, G. W. (2015) · Science · doi:10.1126/science.aad2459 · Cited by 444
Hoffman, G. R., Rahal, R., Buxton, F., Xiang, K., McAllister, G., Frias, E., Bagdasarian, L., Huber, J., Lindeman, A., Chen, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316793111 · Cited by 421
Self-citationMitochondrial quality control: a matter of life and death for neurons
Rugarli, E. I., & Langer, T. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.38 · Cited by 419
CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes
Evers, B., Jastrzebski, K., Heijmans, J. P. M., Grernrum, W., Beijersbergen, R. L., & Bernards, R. (2016) · Nature Biotechnology · doi:10.1038/nbt.3536 · Cited by 417
Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes
Morgens, D. W., Deans, R. M., Li, A., & Bassik, M. C. (2016) · Nature Biotechnology · doi:10.1038/nbt.3567 · Cited by 401
Fung, H.-C., Scholz, S., Matarin, M., Simón-Sánchez, J., Hernandez, D., Britton, A., Gibbs, J. R., Langefeld, C., Stiegert, M. L., Schymick, J., et al. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70578-6 · Cited by 389
High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy
Hasson, S. A., Kane, L. A., Yamano, K., Huang, C.-H., Sliter, D. A., Buehler, E., Wang, C., Heman-Ackah, S. M., Hessa, T., Guha, R., et al. (2013) · Nature · doi:10.1038/nature12748 · Cited by 365
Wapl is an essential regulator of chromatin structure and chromosome segregation
Tedeschi, A., Wutz, G., Huet, S., Jaritz, M., Wuensche, A., Schirghuber, E., Davidson, I. F., Tang, W., Cisneros, D. A., Bhaskara, V., et al. (2013) · Nature · doi:10.1038/nature12471 · Cited by 359 · cited 1×
“S3), which have been linked to cell cycle progression (45).”
BackgroundA probability-based approach for the analysis of large-scale RNAi screens
König, R., Chiang, C.-Y., Tu, B. P., Yan, S. F., DeJesus, P. D., Romero, A., Bergauer, T., Orth, A., Krueger, U., Zhou, Y., et al. (2007) · Nature Methods · doi:10.1038/nmeth1089 · Cited by 338
Yun, J., Puri, R., Yang, H., Lizzio, M. A., Wu, C., Sheng, Z.-H., & Guo, M. (2014) · eLife · doi:10.7554/elife.01958 · Cited by 303
O-GlcNAc Transferase Catalyzes Site-Specific Proteolysis of HCF-1
Capotosti, F., Guernier, S., Lammers, F., Waridel, P., Cai, Y., Jin, J., Conaway, J. W., Conaway, R. C., & Herr, W. (2011) · Cell · doi:10.1016/j.cell.2010.12.030 · Cited by 252
Fanconi Anemia Proteins Function in Mitophagy and Immunity
Sumpter, R., Sirasanagandla, S., Fernández, Á. F., Wei, Y., Dong, X., Franco, L., Zou, Z., Marchal, C., Lee, M. Y., Clapp, D. W., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.006 · Cited by 250 · cited 1×
““Fanconi anemia nuclear complex” represented one of the smallest enriched sets and has been linked to PARKIN and mitophagy (26).”
BackgroundRSAT 2015: Regulatory Sequence Analysis Tools
Medina-Rivera, A., Defrance, M., Sand, O., Herrmann, C., Castro-Mondragon, J. A., Delerce, J., Jaeger, S., Blanchet, C., Vincens, P., Caron, C., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv362 · Cited by 245
Rakovic, A., Shurkewitsch, K., Seibler, P., Grünewald, A., Zanon, A., Hagenah, J., Krainc, D., & Klein, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.391680 · Cited by 218
Regulation of mitophagy by the Gp78 E3 ubiquitin ligase
Fu, M., St-Pierre, P., Shankar, J., Wang, P. T. C., Joshi, B., & Nabi, I. R. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-08-0607 · Cited by 204
Lacoste, A., Berenshteyn, F., & Brivanlou, A. H. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.07.011 · Cited by 201
Ronin Is Essential for Embryogenesis and the Pluripotency of Mouse Embryonic Stem Cells
Dejosez, M., Krumenacker, J. S., Zitur, L. J., Passeri, M., Chu, L.-F., Songyang, Z., Thomson, J. A., & Zwaka, T. P. (2008) · Cell · doi:10.1016/j.cell.2008.05.047 · Cited by 200
Liani, E., Eyal, A., Avraham, E., Shemer, R., Szargel, R., Berg, D., Bornemann, A., Riess, O., Ross, C. A., Rott, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401081101 · Cited by 193
Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes
Rose, C. M., Isasa, M., Ordureau, A., Prado, M. A., Beausoleil, S. A., Jedrychowski, M. P., Finley, D. J., Harper, J. W., & Gygi, S. P. (2016) · Cell Systems · doi:10.1016/j.cels.2016.08.009 · Cited by 178
Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
Gong, Y., Zack, T. I., Morris, L. G. T., Lin, K., Hukkelhoven, E., Raheja, R., Tan, I.-L., Turcan, S., Veeriah, S., Meng, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.2981 · Cited by 177
Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62
DeJesus, R., Moretti, F., McAllister, G., Wang, Z., Bergman, P., Liu, S., Frias, E., Alford, J., Reece-Hoyes, J. S., Lindeman, A., et al. (2016) · eLife · doi:10.7554/elife.17290 · Cited by 145
Self-citationPARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation
Gupta, A., Anjomani-Virmouni, S., Koundouros, N., Dimitriadi, M., Choo-Wing, R., Valle, A., Zheng, Y., Chiu, Y.-H., Agnihotri, S., Zadeh, G., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.019 · Cited by 134
Ivatt, R. M., Sanchez-Martinez, A., Godena, V. K., Brown, S., Ziviani, E., & Whitworth, A. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321207111 · Cited by 130 · cited 1×
“S3) were also identified in a previous genetic screen as positive regulators of mitophagy (13).”
BackgroundDejosez, M., Levine, S. S., Frampton, G. M., Whyte, W. A., Stratton, S. A., Barton, M. C., Gunaratne, P. H., Young, R. A., & Zwaka, T. P. (2010) · Genes & Development · doi:10.1101/gad.1935210 · Cited by 125
Parkin Regulates Mitosis and Genomic Stability through Cdc20/Cdh1
Lee, S. B., Kim, J. J., Nam, H.-J., Gao, B., Yin, P., Qin, B., Yi, S. Y., Ham, H., Evans, D. L., Kim, S., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.08.011 · Cited by 101
Hexokinase activity is required for recruitment of parkin to depolarized mitochondria
McCoy, M. K., Kaganovich, A., Rudenko, I. N., Ding, J., & Cookson, M. R. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt407 · Cited by 97
Lefebvre, V., Du, Q., Baird, S., Ng, A. C.-H., Nascimento, M., Campanella, M., McBride, H. M., & Screaton, R. A. (2013) · Autophagy · doi:10.4161/auto.25413 · Cited by 78
A Transcriptional Regulatory Role of the THAP11–HCF-1 Complex in Colon Cancer Cell Function
Parker, J. B., Palchaudhuri, S., Yin, H., Wei, J., & Chakravarti, D. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06033-11 · Cited by 68
Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson’s disease
Shiba-Fukushima, K., Ishikawa, K.-I., Inoshita, T., Izawa, N., Takanashi, M., Sato, S., Onodera, O., Akamatsu, W., Okano, H., Imai, Y., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx201 · Cited by 64
Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter
Hasson, S. A., Fogel, A. I., Wang, C., MacArthur, R., Guha, R., Heman-Ackah, S., Martin, S., Youle, R. J., & Inglese, J. (2015) · ACS Chemical Biology · doi:10.1021/cb5010417 · Cited by 54
Schuierer, S., & Roma, G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw538 · Cited by 43
Self-citationInduction of parkin expression in the presence of oxidative stress
Yang, Y., Muqit, M. M. K., & Latchman, D. S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04998.x · Cited by 41
Poché, R. A., Zhang, M., Rueda, E. M., Tong, X., McElwee, M. L., Wong, L. Y. E., Hsu, C., Déjosez, M., Burns, A. R., Fox, D. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.039 · Cited by 39
Cited by
A brief history of human disease genetics
Claussnitzer, M., Cho, J. H., Collins, R., Cox, N. J., Dermitzakis, E. T., Hurles, M. E., Kathiresan, S., Kenny, E. E., Lindgren, C. M., MacArthur, D. G., et al. (2020) · Nature · doi:10.1038/s41586-019-1879-7 · Cited by 697
Bock, C., Datlinger, P., Chardon, F., Coelho, M. A., Dong, M. B., Lawson, K. A., Lu, T., Maroc, L., Norman, T. M., Song, B., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00093-4 · Cited by 571
Mitochondrial dysfunction and mitophagy in parkinson’s disease: from mechanism to therapy
Malpartida, A. B., Williamson, M., Narendra, D. P., Wade-Martins, R., & Ryan, B. J. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.11.007 · Cited by 482
A new era in functional genomics screens
Przybyla, L., & Gilbert, L. A. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00409-w · Cited by 281
Mitochondrial quality control in health and in Parkinson’s disease
Eldeeb, M. A., Thomas, R. A., Ragheb, M. A., Fallahi, A., & Fon, E. A. (2022) · Physiological Reviews · doi:10.1152/physrev.00041.2021 · Cited by 265
Metadata
- Authors
- Potting, C., Crochemore, C., Moretti, F., Nigsch, F., Schmidt, I., Manneville, C., Carbone, W., Knehr, J., DeJesus, R., Lindeman, A., Maher, R., Russ, C., McAllister, G., Reece-Hoyes, J. S., Hoffman, G. R., Roma, G., Müller, M., Sailer, A. W., & Helliwell, S. B.
- Affiliations
- Novartis (Switzerland) (CH)
- Novartis Institutes for BioMedical Research, Cambridge, MA 02139
- Novartis Institutes for BioMedical Research, Basel CH 4002, Switzerland;
- Corresponding author
- Helliwell, Stephen B.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-12-21
- Volume
- 115
- Issue
- 2
- Pages
- E180-E189
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5777035
- OpenAlex
- W2776435687
- Cited by
- 93
- References
- 63
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 8 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 20 · 2019: 19 · 2018: 2
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-08-27)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkin, mitophagy, transcriptional repression, Parkinson's disease, mitochondrial damage, autophagy signaling, gene expression regulation, neurons, CRISPR screen
- MeSH terms
- PTEN-Induced Putative Kinase, Cells, Cultured, Gene Expression Regulation, Humans, Infant, Newborn, Neurons, Phosphorylation, Protein Kinases, Repressor Proteins, Genome, Human, Ubiquitin, Ubiquitin-Protein Ligases, HCT116 Cells, Cell Line, Tumor, Induced Pluripotent Stem Cells, HEK293 Cells, Mitophagy, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.